Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TRC105 with Chemo and Bevacizumab in Stage 4 Non-Squamous NSCLC
NCT02429843Phase 1Completed
- Sponsor
- University of Alabama at Birmingham
- Start
- Nov 2015
- Primary completion
- Dec 2018
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of carotuximab in non-small cell lung cancer (NSCLC), sponsored by University of Alabama at Birmingham. Primary endpoint: Number of patients with a change in medical management. Started Nov 2015; status: completed.
02
Drugs
carotuximab
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT02429843.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02429843.